Neoclease

Neoclease enables targeted gene editing with AI-designed nucleases to treat genetic diseases with greater precision. It uses synthetic biology and generative AI to design custom nucleases, leveraging GPT neural networks to tailor enzymes to individual genes. The core tech includes computational chemistry and molecular dynamics simulations to optimize specificity, efficiency, and delivery. Neoclease operates as a B2B SaaS/services model for biotech researchers and gene therapy developers, with programs such as LRRK2 for Parkinson's disease.

AI-driven SolutionsCustom NucleasesEnzymatic LibrariesGene EditingGenerative AIGenetic DiseasesPrecision MedicineSynthetic Biologyneoclease.ai

Neoclease

AI-driven SolutionsCustom NucleasesEnzymatic LibrariesGene EditingGenerative AIGenetic DiseasesPrecision MedicineSynthetic Biologyneoclease.ai

HQBoston, US

Team Size5

Open JobsUnknown

Total Funding-

Latest FundraiseUnknown

Join the Team

Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.

Technical Writer

ContractTel Aviv

Contract • Tel Aviv

Technical Writer

ContractNovi Sad, RS

Contract • Novi Sad, RS

Frontend Developer

Full-timeNew York, US

Full-time • New York, US

Data Scientist

Part-timeHaifa

Part-time • Haifa

Technical Writer

InternshipCambridge, GB

Internship • Cambridge, GB

Machine Learning Engineer

Part-timeNew York, US

Part-time • New York, US